In 2020, the UC Davis School of Medicine secured its highest-ever level of National Institutes of Health (NIH) funding at more than $181 million, an increase of about $4.7 million compared to the previous year.
UC Davis School of Medicine Office of Research
The School of Medicine Office of Research (SOMOR) manages research awards and proposals, oversees laboratory safety and research space, provides researchers with guidance and support for grant submissions, promotes entrepreneurial initiatives, and facilitates industry alliances and program evaluation.
The Research Operations unit facilitates research grant proposals, limited submissions, award nominations, Bridge Funding assessment and research data analytics.
The Grants Facilitation unit supports School of Medicine researchers in their grant writing, manuscript editing, and professional development.
The Industry Alliances unit directs industry partner agreements, advises on business and financial matters and supports entrepreneurial translation of discoveries from insight to innovation.
The Evaluation unit collaborates with programs to design evaluation plans with clear, measurable goals and optimal use of resources.
The Safety Management program sets standards for research safety management as well as individual laboratory safety programs and activities.
Research Space Oversight
The Research Space Oversight unit supervises all School of Medicine research space assessments, allocations, and recommendations.
School of Medicine scored a record year of NIH funding
About Aggie Square
Located on the UC Davis Sacramento Campus, Aggie Square will house business partners and community-based programs with UC Davis innovation and research to create a stronger and healthier shared community.
UC Davis schools of nursing and medicine receive high national rankings
The Betty Irene Moore School Nursing at UC Davis and UC Davis School of Medicine continue to achieve national prestige in U.S. News & World Report's 2022 graduate school rankings recently released. The School of Medicine was named No. 4 for its diversity and No. 9 in family medicine. It also maintained high rankings in primary care and research.
First stem cell clinical trial for spina bifida treatment announced
UC Davis Health recently announced the launch of the world’s first, FDA-approved human clinical trial using stem cells before birth to treat the most serious form of spina bifida. The one-of-a-kind treatment will be delivered while the baby is still in the mother’s womb (in utero). It will be the standard surgical procedure combined with the use of a unique stem cell “patch” to repair the defect before birth.
UC Davis approved as Center of Comprehensive Care for Pulmonary Hypertension
UC Davis Health has been reaccredited as a Center of Comprehensive Care from the Pulmonary Hypertension Association (PHA). This is the highest level of accreditation granted by the PHA. The designation recognizes the high quality and depth of resources available at UC Davis Health for the expert care of patients with pulmonary hypertension.